Sandoz Group (SDZNY) News Today $42.21 +0.52 (+1.25%) As of 03/27/2025 03:50 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sandoz price target raised to CHF 44 from CHF 42 at RBC CapitalMarch 27 at 7:53 PM | markets.businessinsider.comBerenberg Bank Sticks to Their Hold Rating for Sandoz Group Ltd (SDZXF)March 18, 2025 | theglobeandmail.comSandoz Group Ltd (SDZXF) Gets a Buy from Kepler CapitalMarch 18, 2025 | theglobeandmail.comSandoz signs landmark supply and manufacturing agreementMarch 18, 2025 | globenewswire.comSandoz Group AG (OTCMKTS:SDZNY) Sees Significant Decrease in Short InterestSandoz Group AG (OTCMKTS:SDZNY - Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 54,700 shares, a drop of 85.1% from the February 13th total of 366,500 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 53,600 shares, the days-to-cover ratio is presently 1.0 days.March 13, 2025 | marketbeat.comSandoz price target lowered to CHF 38 from CHF 41 at Morgan StanleyMarch 12, 2025 | markets.businessinsider.comSandoz Group AG (SDZNY) (Q4 2024) Earnings Call Highlights: Record Sales and Strategic Growth ...March 6, 2025 | gurufocus.comSandoz Group: Sandoz reports strong FY 2024 results and Q4 2024 salesMarch 5, 2025 | finanznachrichten.deSandoz reports strong FY 2024 results and Q4 2024 salesMarch 5, 2025 | globenewswire.comAvecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in AustraliaMarch 3, 2025 | prnewswire.comSandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in FebruarySandoz Group AG (OTCMKTS:SDZNY - Get Free Report) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 366,500 shares, a decline of 52.6% from the January 31st total of 773,500 shares. Based on an average daily volume of 95,900 shares, the days-to-cover ratio is currently 3.8 days.March 2, 2025 | marketbeat.comSandoz Group Ltd (SDZXF) Receives a Hold from UBSFebruary 28, 2025 | markets.businessinsider.comSandoz family foundation offers $3 billion worth of Novartis sharesFebruary 25, 2025 | reuters.comSandoz launches Pyzchiva in the U.S.February 24, 2025 | markets.businessinsider.comSandoz Group: Sandoz launches biosimilar Pyzchiva (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]February 24, 2025 | finanznachrichten.deSandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]February 24, 2025 | globenewswire.comSandoz Group Ltd (SDZXF) Gets a Buy from BarclaysFebruary 18, 2025 | markets.businessinsider.comSandoz price target raised to CHF 41 from CHF 35 at Morgan StanleyFebruary 12, 2025 | markets.businessinsider.comSandoz Group (OTCMKTS:SDZNY) Sets New 52-Week High - Here's WhySandoz Group (OTCMKTS:SDZNY) Hits New 52-Week High - Time to Buy?February 11, 2025 | marketbeat.comUBS Group Downgrades Sandoz Group (OTCMKTS:SDZNY) to HoldUBS Group downgraded shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a report on Monday.February 6, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Sets New 1-Year High - Still a Buy?Sandoz Group (OTCMKTS:SDZNY) Hits New 12-Month High - Here's WhyFebruary 5, 2025 | marketbeat.comSandoz Group: Francisco Ballester to retire; Peter Stenico appointed President Region InternationalFebruary 3, 2025 | finanznachrichten.deSandoz Group Appoints Peter Stenico As President Region IntlFebruary 3, 2025 | markets.businessinsider.comFrancisco Ballester to retire; Peter Stenico appointed President Region InternationalFebruary 3, 2025 | globenewswire.comNovartis Q4 Core EPS Beats Market, Hikes Dividend; Sees Growth In FY25; Stock Up January 31, 2025 | rttnews.comBerenberg Bank Remains a Hold on Sandoz Group Ltd (SDZXF)January 30, 2025 | markets.businessinsider.comSandoz price target raised to CHF 41 from CHF 39 at BerenbergJanuary 30, 2025 | markets.businessinsider.comSandoz Group (OTCMKTS:SDZNY) Sets New 1-Year High - Here's What HappenedSandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High - Still a Buy?January 30, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Sets New 12-Month High - Should You Buy?Sandoz Group (OTCMKTS:SDZNY) Hits New 12-Month High - What's Next?January 23, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Stock Price Down 1% - Here's What HappenedSandoz Group (OTCMKTS:SDZNY) Stock Price Down 1% - Should You Sell?January 18, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Shares Down 1% - Should You Sell?Sandoz Group (OTCMKTS:SDZNY) Shares Down 1% - Here's What HappenedJanuary 18, 2025 | marketbeat.comSandoz Group: Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 14, 2025 | finanznachrichten.deSandoz: Global Generics And Biosimilars Market To Grow At 7% Annual Compound Rate For Next 10 YearsJanuary 14, 2025 | markets.businessinsider.comSandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 14, 2025 | globenewswire.comSandoz Group (OTCMKTS:SDZNY) Shares Up 1% - Here's WhySandoz Group (OTCMKTS:SDZNY) Trading Up 1% - Here's WhyDecember 27, 2024 | marketbeat.comSandoz Boss Warns There’s a Climate Cost of Obesity Wonder DrugsDecember 21, 2024 | bloomberg.comSandoz Agrees on $275 Million Settlement in U.S. Price-Fixing CaseDecember 19, 2024 | msn.comSandoz Agrees 275 Mn Settlement Of US Class ActionDecember 17, 2024 | barrons.comSandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action LitigationDecember 17, 2024 | markets.businessinsider.comSandoz To Pay $275 Mln To Resolve US Generic Drug Litigation, Plans $265 Mln Provision; Backs ViewDecember 17, 2024 | markets.businessinsider.comSandoz Charts Path to Swift Generic Ozempic Launch in CanadaDecember 11, 2024 | financialpost.comSandoz Group (OTC:SDZNY) Stock Quotes, Forecast and News SummaryDecember 4, 2024 | benzinga.comSandoz Group (OTCMKTS:SDZNY) Trading Up 0.8% - Should You Buy?Sandoz Group (OTCMKTS:SDZNY) Trading 0.8% Higher - Still a Buy?November 26, 2024 | marketbeat.comAgomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of DirectorsNovember 18, 2024 | businesswire.comSandoz receives EC approval for AfqlirNovember 16, 2024 | markets.businessinsider.comSandoz : EC Approves Afqlir 2 Mg Vial Kit & Pre-filled Syringe For Intravitreal InjectionNovember 15, 2024 | markets.businessinsider.comSandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolioNovember 15, 2024 | globenewswire.comSandoz price target raised to CHF 36 from CHF 33 at Deutsche BankNovember 6, 2024 | markets.businessinsider.comSandoz price target raised to CHF 39 from CHF 38 at BerenbergNovember 2, 2024 | markets.businessinsider.comSandoz price target raised to CHF 35 from CHF 32 at Morgan StanleyNovember 1, 2024 | markets.businessinsider.com Remove Ads Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SDZNY Media Mentions By Week SDZNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SDZNY News Sentiment▼-0.500.78▲Average Medical News Sentiment SDZNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SDZNY Articles This Week▼21▲SDZNY Articles Average Week Remove Ads Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VCISY News KDDIY News CNSWF News ITOCY News HNHPF News BCMXY News MHVYF News BAESY News SHECY News CAIXY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SDZNY) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sandoz Group AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Sandoz Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SDZNY Stock Free SDZNY Stock Alerts